Paper Details

  1. Home
  2. Paper Details

Botulinum toxin-B injection into the lacrimal gland and posterior cricoarytenoid muscle for the treatment of epiphora and abductor spasmodic dysphonia secondary to Parkinson's disease.

Author: CostelloDeclan, MadgeSimon, SachdevAmun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

In a case report, botulinum toxin type-B (BTX-B) injections into the lacrimal gland significantly improved epiphora in a 53-year-old male with Parkinson's disease who did not respond to BTX-A injections. BTX-B injections into the PCA muscle also significantly improved his spasmodic dysphonia.
Paper Details　
Original Abstract of the Article :
In ophthalmology, there have been few reports of botulinum toxin type-A (BTX-A) injection into the lacrimal gland to treat epiphora. In ENT, adductor and abductor (ABSD) spasmodic dysphonia are often treated with BTX-A injections into the respective overacting vocal cord muscles. We describe a 53-ye...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/01676830.2018.1490443

データ提供：米国国立医学図書館（NLM）

Botulinum Toxin-B: A Novel Weapon Against Parkinson's Disease Symptoms

The [Parkinson's disease] landscape is fraught with challenges, with patients often experiencing debilitating symptoms such as [epiphora] and [abductor spasmodic dysphonia (ABSD)]. This study, like a camel caravan seeking innovative solutions, explores the potential of [botulinum toxin type-B (BTX-B)] injections in treating these symptoms. The study presents a case report of a patient with Parkinson's disease who experienced significant improvement in both epiphora and ABSD following BTX-B injections, highlighting the potential of this novel approach in managing these challenging symptoms.

BTX-B: A Promising Treatment for Parkinson's Disease Symptoms

The study demonstrates the remarkable efficacy of BTX-B injections in treating both epiphora and ABSD in a patient with Parkinson's disease. This finding, like a shimmering oasis in the desert, offers a beacon of hope for patients struggling with these debilitating symptoms. The study suggests a new avenue for managing these challenges and improving quality of life for patients with Parkinson's disease.

Hope on the Horizon: BTX-B for Parkinson's Disease Symptoms

The study's findings, like a refreshing breeze in the desert, offer a glimmer of hope for patients with Parkinson's disease. The potential for BTX-B injections to alleviate debilitating symptoms like epiphora and ABSD is truly encouraging. This innovative approach could significantly improve the lives of patients, allowing them to navigate their daily challenges with greater ease.

Dr.Camel's Conclusion

This case report provides compelling evidence for the efficacy of botulinum toxin type-B injections in treating epiphora and abductor spasmodic dysphonia in patients with Parkinson's disease. The study highlights the potential of this novel approach to significantly improve the quality of life for patients struggling with these debilitating symptoms. Further research is needed to confirm these findings and explore the long-term effects of BTX-B in this population.

Date :
  1. Date Completed 2020-01-10
  2. Date Revised 2020-01-10
Further Info :

Pubmed ID

29939826

DOI: Digital Object Identifier

10.1080/01676830.2018.1490443

Related Literature

Article Analysis
・Effects of rimabotulinumtoxinb injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.